How big is Health Catalyst, Inc.?

As of Jun 18, Health Catalyst, Inc. has a market capitalization of 265.18 million, with net sales of 311.27 million and a net profit of -72.66 million over the latest four quarters.

As of Jun 18, Health Catalyst, Inc. has a market capitalization of 265.18 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company's net sales for the latest four quarters amount to 311.27 million, while the net profit for the same period is reported at -72.66 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds of 365.21 million and total assets of 858.93 million.

What does Health Catalyst, Inc. do?

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations, with recent net sales of $79 million and a net loss of $24 million. The company has a market cap of $265.18 million and operates as a micro-cap entity.

Overview:<BR>Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations, operating within the Software Products industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 79 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -24 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 265.18 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.12 <BR>Return on Equity: -15.01% <BR>Price to Book: 0.70<BR><BR>Contact Details:<BR>Address: 3165 E Millrock Dr Ste 400, SALT LAKE CITY UT: 84121-4772 <BR>Tel: ['1 801 7086800', '1 855 3096800'] <BR>Fax: 1 302 6555049 <BR>Website: https://www.healthcatalyst.com/

Should I buy, sell or hold Health Catalyst, Inc.?

Who are in the management team of Health Catalyst, Inc.?

As of March 2022, the management team of Health Catalyst, Inc. includes Mr. Fraser Bullock (Chairman), Mr. Daniel Burton (CEO), and several independent directors: Dr. Timothy Ferris, Mr. Todd Cozzens, Mr. Duncan Gallagher, Mr. John Kane, and Ms. Julie Larson-Green. They are responsible for the company's strategic direction and operations.

As of March 2022, the management team of Health Catalyst, Inc. includes the following individuals:<BR><BR>- Mr. Fraser Bullock, Independent Chairman of the Board<BR>- Mr. Daniel Burton, Chief Executive Officer and Director<BR>- Dr. Timothy Ferris, Director<BR>- Mr. Todd Cozzens, Independent Director<BR>- Mr. Duncan Gallagher, Independent Director<BR>- Mr. John Kane, Independent Director<BR>- Ms. Julie Larson-Green, Independent Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Is Health Catalyst, Inc. technically bullish or bearish?

As of September 10, 2025, Health Catalyst, Inc. is in a bearish trend with weak strength, underperforming the S&P 500 significantly, with year-to-date and one-year returns of -57.28% and -65.45%, respectively.

As of 10 September 2025, the technical trend for Health Catalyst, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, as indicated by the daily moving averages and the bearish signals from the Bollinger Bands and KST. The weekly MACD shows a mildly bullish trend, but this is overshadowed by the monthly bearish RSI and the overall bearish sentiment in the Dow Theory. <BR><BR>In terms of performance, Health Catalyst has significantly underperformed compared to the S&P 500, with a year-to-date return of -57.28% versus the S&P 500's 12.22%, and a one-year return of -65.45% compared to the S&P 500's 17.14%.